Filter
731
Text search:
viral
suppression
Featured
Recommendations
61
New Publications
203
Language
Document type
No document type
478
Guidelines
106
Studies & Reports
101
Strategic & Response Plan
12
Fact sheets
11
Infographics
9
Manuals
8
Situation Updates
3
Training Material
2
Brochures
1
Countries / Regions
South Africa
30
Kenya
29
India
27
Africa
21
Global
20
Zambia
19
Malawi
19
Ethiopia
15
Tanzania
15
Nepal
12
Asia
12
Nigeria
11
Uganda
11
Lesotho
9
Myanmar / Burma
8
Ghana
7
Zimbabwe
7
Namibia
7
East and Southern Africa
6
Latin America and the Carribbean
6
Cambodia
5
Rwanda
5
Brazil
5
Western and Central Europe
5
Liberia
4
Philippines
4
Ukraine
4
Venezuela
4
Georgia
4
Burkina Faso
3
Sierra Leone
3
Senegal
3
Congo, Democratic Republic of
3
Cameroon
3
Bangladesh
3
Mozambique
3
Eswatini/ Swaziland
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Eastern Europe
3
Albania
3
Russia
3
Germany
2
Thailand
2
Botswana
2
Madagascar
2
West and Central Africa
2
Paraguay
2
Armenia
2
Vietnam
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Niger
1
Togo
1
Haiti
1
Somalia
1
Pakistan
1
Indonesia
1
Benin
1
Serbia
1
Burundi
1
Angola
1
Chile
1
Middle East and North Africa
1
Luxembourg
1
Djibouti
1
Southern Africa
1
Congo-Brazzaville
1
Canada
1
Estonia
1
Belgium
1
France
1
Authors & Publishers
Publication Years
Category
Countries
270
Clinical Guidelines
69
Public Health
21
Women & Child Health
9
Key Resources
4
Capacity Building
2
Pharmacy & Technologies
2
Annual Report MEDBOX
1
Toolboxes
HIV
342
COVID-19
39
TB
21
Rapid Response
13
Mental Health
11
AMR
10
NCDs
8
NTDs
7
Zika
5
Refugee
4
Pharmacy
4
Global Health Education
3
Polio
2
Specific Hazards
2
Ebola
1
Planetary Health
1
Health Financing Toolbox
1
In line with its decentralization principle, the Ethiopian Health Policy has achieved great progress in improving access to comprehensive HIV/AIDS services to the majority of the population. Both quality and coverage of services have improved significantlysince the initiation
...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
This National Prevention Road Map addresses the above-mentioned challenges and aims to guide, focus and reinvigorate the HIV prevention response during the period 2018-2020. It also renews the commitment of political leadership,
Five years after a global commitment to Fast-Track the HIV response and end AIDS by 2030, the world is off track. A promise to build on the momentum created in the first decade of the twenty-first century by front-loading investment and accelerating HIV service provision has been fulfilled by too fe
...
Five years after a global commitment to Fast-Track the HIV response and end AIDS by 2030, the world is off track. A promise to build on the momentum created in the first decade of the twenty-first century by front-loading investment and accelerating HIV service provision has been fulfilled by too fe
...
The National AIDS Control Council recognizes the growing, organized and progressive inter-faith religious voice in the spheres of governance and development in Kenya. Across the country, the Faith Sector has been involved in HIV prevention, treatment, care and support to programmes towards
...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th
...
The new Global AIDS Strategy 2021--2026, End Inequalities, End AIDS, is a bold approach that uses an inequalities lens to close the gaps preventing progress to end AIDS
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
3 June 2021. After 40 years of AIDS, charting a course to end the pandemic.
The report shows that countries with progressive laws and policies and strong and inclusive health systems have had the best outcomes against HIV. In those countries, people living with and affected by HIV are more likely t
...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in
...
BMC Public Health (2021) 21:299 https://doi.org/10.1186/s12889-021-10296-9
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been
...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th
...
Milestones in the treatment, care and support, Dec 2021
This document synthesizes key elements of the World Health Organization (WHO) normative guidance on health policy and system support for community health worker (CHW) programmes and their application for HIV programmes. Building on relevant elements of HIV guidelines, tools and evidence identified b
...
These guidelines provide a framework for effective action to facilitate access to safe and ethical
testing services for different population groups. The implementation of the a comprehensive
approach, known as HIV Testing Services (HTS) is cardinal as an effective package of services
that diminis
...
9 Febr. 2022
The COVID Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine explainer includes key vaccine specific information on the vaccine specific requirements.
an approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios, first issued 20 October 2020, updated: 13 November 2020, updated: 16 July 2021, latest update: 21 January 2022
Available in English, F
...
